Status of Malaria Infection among Pregnant Women Attending General Hospital Aliero, Kebbi State, Nigeria

Isyaku N. T., Kele M. K.

Abstract


Malaria in pregnancy is one of the  most important preventable causes of low birth weight deliveries, and it is the major causes of severe maternal anemia leading to maternal morbidity and mortality. This study was designed to evaluate the prevalence of malaria among pregnant women attending General Hospital, Aliero. Blood samples were collected from 200 pregnant women and examined for malaria parasites. The overall prevalence of malaria infection was 60.0%. Malaria prevalence was significantly higher in women of younger age-groups than older women (P<0.05), and based on the trimesters of pregnancy, 2nd trimester (71.4%) had the highest prevalence (P<0.05). There is a strong statistical significant relationship between the prevalence of malaria and mode of treatment. Pregnant women that visit the hospital for malaria treatement had the least prevalence (48.3%), followed by those that embark on self medication (90.0%). The sole individual that combine both methods (visiting hospital and self medication (100%) is infected and those pregnant women that neither visited the hostipal nor take self medication are all infected (100%). Conclusively, malaria control in pregnancy is necessary so as to reduce the incidence of adverse pregnancy complications.


Full Text:

PDF

References


Aliyu, W. I., Mommoh, A. A. (2011).Prevalence of malaria parasitaemia amongst asymptomic pregnant women attending a Nigerian teaching hospital. Annals of African Medicine, 10(2);171-174.

Bahadur, S., Pujani, M., Jain, M. (2011). Use of rapid detection tests to prevent transfusion-transmitted malaria in India. Asian J TransfusSci Vol. (4):140-141.

Caraballo H (2014). "Emergency department management of mosquito-borne illness: Malaria, dengue, and west Nile virus". Emergency Medicine Practice.16 (5): 1–23.

Claire L. Mackintosh, James G. Beeson, Kevin Marsh. Clinical features and pathogenesis of sever malaria, TRENDS in parasitology December (2004);20(12)

Cowman AF, Berry D, Baum J (2012)."The cellular and molecular basis for malaria parasite invasion of the human red blood cell".Journal of Cell Biology.198 (6): 961–71.

Gamble C, Ekwaru JP, terKuile FO, et al. (Cochrane Infectious Diseases Group) (April 2006). "Insecticide-treated nets for preventing malaria in pregnancy". The Cochrane Database of Systematic Reviews (2): CD003755.

Gitau, G.M., Eldred, J.M. (2005). Malaria in pregnancy: clinical, therapeutic and prophylactic considerations. The Obstetrician and Gynaecologist.;7:5-11.

Greenwood, B.M., Bojang, K., Whitty, C.J., Targett, G.A. (2005)."Malaria".Lancet.365 (9469): 1487-1498.

Gunn, J. K., Ehiri, J. E., Jaccob, E. T., Erst, K. C., pettygrove, S., Kohler, L N., Haenchen, S. D., Obiefune, M.C., Ezeanolue, C. O., Ogidi, A. G., and Ezeanolue, E. E. (2015). Population-based prevalence of malaria among pregant women in Enugu State, Nigeria: The healthy beginning initiative. Malaria Journal, 14:438.

Isba, R., Zani, B., Gathu, M., Sinclair D, et al. (Cochrane Infectious Diseases Group) (February, 2015). "Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria".The Cochrane Database of Systematic Reviews (2): CD011547.

Keating, G.M. (2012). "Dihydroartemisinin/piperaquine: A review of its use in the treatment of uncomplicated Plasmodium falciparum malaria". Drugs.72 (7): 937–961.

Larviciding to prevent malaria transmission".The Cochrane Database of Systematic Reviews. 8: CD012736.

Manyando, C., Kayentao, K., D'Alessandro, U., Okafor, H.U., Juma, E., Hamed, K. (2011). "A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy".Malaria Journal.11: 141.

Mbanugo, J. I. and Ejims, D. O. (2000). Plasmodium infections in children aged 0-5 years in Awka Metropolis, Anambra State, Nigeria. Nigeria Journal of Parasitology.21:55-59.

Meremikwu, M.M., Odigwe, C.C., AkudoNwagbara, B., Udoh, E.E. (2012). Meremikwu MM (ed.). "Antipyretic measures for treating fever in malaria". Cochrane Database of Systematic Reviews. 9 (9): CD002151.

Mueller, I., Zimmerman, P.A., Reeder, J.C. (2007). "Plasmodium malariae and Plasmodium ovale the "bashful".MalariaTrendsinParasitology.23 (6): 278–283.

Nadjm, B., Behrens, R.H. (2012). "An malaria parasites update for physicians". Infectious Disease Clinics of North America.26 (2): 243–259.

Onyenekwe, C.C., Meludu, S.C. (2002).Prevalence of asymptomatic malariaparasitaemia amongst pregnant women in Nnewi, south-east Nigeria. Indian Journal of Malariology., Sep-Dec.39(3-4): 60-65.

Pates, H. and Curtis, C. (2005). "Mosquito behaviour and vector control". Annual Review of Entomology.50: 53-70.

Peter Van den Eede et al. (2009).Human plasmoduimknowlesi infections in young children in central vietnam.Malaria Journal;8:249. doi:10.1186/1475-8-249.

Raghavendra, K., Barik, T.K., Reddy, B.P., Sharma, P., Dash, A.P. (2011). "Malaria vector control: From past to future".Parasitology Research.108 (4): 757–779.

Sarkar, P.K., Ahluwalia, G., Vijayan,V.K., Talwar, A. (2009). "Critical care aspects of malaria".Journal of Intensive Care Medicine.25 (2): 93–103.

Scholarpurka, S.L., Mahajar, R.C., Gupta, A.N and Wangoo, A. (1999). Cellular immunity in pregnant and non-pregnant women with malaria infection.Asia Oceania Journal of ObstGyncol.16:27-32.

White, N.J. (2011). "Determinants of relapse periodicity in Plasmodium vivax malaria".MalariaJournal.10: 297.

WHO, (2016). Malaria vaccine: WHO position paper January (2016) (PDF).Weekly Epidemiological Record.91 (4): 33-52.


Refbacks

  • There are currently no refbacks.